The recent advancements in the field of nanomedicine have ushered in innovative techniques for both biomedical imaging and cancer treatment. A significant contribution to this field was made by the Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP), Brazil. Their pioneering research focuses on engineered nanoparticles that demonstrate enhanced intrinsic luminescence, providing new opportunities for non-invasive imaging and targeted drug delivery.

Intrinsic Luminescence of Hydroxyapatite Nanoparticles

The researchers discovered a method to transform hydroxyapatite, a bioceramic material, into nanoparticles that exhibit enhanced intrinsic luminescence. This enhancement is attributed to the incorporation of carbonate groups into the hydroxyapatite structure, which increases the concentration of crystal defects. These defects play a crucial role in enhancing the luminescence of the material. Thales Rafael Machado, the first author of the research, elaborated that after functionalization with citrate, the calcium phosphate nanoparticles produced are able to serve as luminescent agents for cellular bioimaging.

Mechanism of Enhancement

The team meticulously controlled the concentration of structural and point defects in hydroxyapatite nanoparticles by varying the levels of carbonate during the synthesis process. The sample possessing the highest carbonate content exhibited the most intense luminescence.

“The bioimaging capability was demonstrated by visualizing the internalization of the nanoparticles into cells, relying exclusively on their intrinsic luminescence,” – Thales Rafael Machado

Internalization was confirmed through flow cytometry based on the luminescent signal emitted by the particles, and biocompatibility was assessed using cellular cytotoxicity assays. The research provides a solid foundation for photonic applications in biomedicine, including spectroscopic studies tailored for hard tissues such as bones and teeth.

Applications in Cancer Treatment

In a parallel study, the same research group, along with the Center for Molecular Engineering of Advanced Materials (CEMol), developed an effective strategy for delivering the chemotherapy drug gemcitabine—a treatment commonly used for pancreatic cancer—using calcium phosphate nanoparticles. This system is designed to keep the drug inactive under normal physiological conditions while releasing it in its active form in acidic environments typically found in tumor regions.

Controlled Release Mechanism

This innovative approach allows for greater bioavailability and therapeutic potential of the drug. Additionally, the nanoparticles can be functionalized with folic acid through stable covalent bonds, which serve as a targeting molecule; many tumor cells demonstrate a higher demand for folate.

Feature Description
Controlled Drug Release Drug remains inactive in bloodstream, activated in acidic tumor environments.
Targeting with Folate Folic Acid enhances targeting to folate-receptive tumor cells.
Biocompatibility Calcium phosphate is naturally present in the human body, ensuring safety.

Potential Impact on Patient Care

This system's unique combination of controlled release and active targeting has demonstrated a significant ability to enhance drug concentrations in cancer cells while minimizing exposure to healthy tissues.

Machado states, “By keeping the drug inactive while it circulates in the body and releasing it preferentially in the tumor environment, this intelligent drug delivery system promises to minimize side effects and maximize therapeutic efficacy.”

The approach represents a significant advancement in nanomedicine, enhancing the efficiency of chemotherapy while also improving the quality of life for patients undergoing treatment.

Research Publications

The findings from these studies have been published in leading journals, detailing both the fundamental and applied aspects of the research:

  • Thales R. Machado et al, Defect-Related Photoluminescence in Hydroxyapatite Nanoparticles Modulated by Carbonate Incorporation, ACS Nanoscience Au (2025).
  • Thales R. Machado et al, Dual pH-Responsive Calcium Phosphate Nanoparticles Conjugated with Folate by CuAAC Click Chemistry for Targeted Gemcitabine Delivery to Cancer Cells, ACS Applied Bio Materials (2025).

For further details, you can access the articles here.

The progress made by this research team not only highlights innovative approaches to enhancing cancer treatment but also opens new avenues for applications in environmental science and tissue engineering.